NCT03120533 - Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 20, 2017

Primary Completion Date

June 3, 2019

Study Completion Date

June 3, 2019

Conditions

Scleroderma, Systemic

Interventions

DRUG

Iontophoresis of treprostinil

the participant will receive 10 days of iontophoresis of treprostinil on a first site

DRUG

Iontophoresis of placebo

the participant will receive 10 days of iontophoresis of NaCl on a second site, but the same time than treprostinil; it's like a design of cross-over study

Trial Locations (1)

38043

Grenoble Alps University Hospital, Grenoble